Objective: To investigate the relationship between the polymorphism of miR-155 and its target gene MyD88 and clinicopathological features of diffuse large B-cell lymphoma (DLBCL).
Methods: 135 cases of DLBCL patients in our hospital from March 2015 to August 2017 were selected, and 90 cases of reactive hyperplasia of lymph nodes were selected as the control group. The relative expression of miR-155 and MyD88 gene polymorphism were detected in the two groups, and the relationship between miR-155 and MyD88 gene polymorphism and clinicopathological characteristics of DLBCL was analyzed.
Results: The relative expression of miR-155 in DLBCL patients was significantly higher than that in the control group (P<0.05). The mutation rate of MyD88 L265P in DLBCL group was significantly higher than that in control group (P<0.05). The relative expression of miR-155 in patients with MyD88 L265P mutation was significantly higher than that in patients with wild-type DLBCL (P<0.05). The relative expression of miR-155 and the polymorphism of MyD88 L265P were associated with lesion location, stage, BCL-2 protein expression and MyD88 protein expression in DLBCL patients (t=7.461、8.804、6.487、10.812； χ=10.681、8.599、7.251、23.008；P<0.05). The survival of DLBCL patients with low miR-155 expression was significantly better than that with high miR-155 expression (P<0.05). The survival of wild-type DLBCL patients with MyD88 L265P locus was significantly better than that of mutant DLBCL patients (P<0.05). There was a significant positive correlation between the relative expression of miR-155 and the expression of MyD88 protein (r=0.428, P=0.000).
Conclusion: The abnormal expression of miR-155 and the mutation rate of MyD88 gene in DLBCL patients are increased, and the expression of miR-155 and the mutation of MyD88 gene affect the disease progression and prognosis of patients, which may be potential biological indicators for the diagnosis, treatment and prognosis of DLBCL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.19746/j.cnki.issn.1009-2137.2021.03.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of miRNA Gene Variants (miR-22 and miR-155) as the Factors Affecting Susceptibility to Panic Disorder.
Clin Psychopharmacol Neurosci
November 2024
Department of Statistics, Faculty of Science, Cankiri Karatekin University, Cankiri, Turkey.
Article Synopsis
- Study examined the impact of microRNA gene variants miR-155 rs767649 and miR-22 rs8076112 on panic disorder (PD) risk in a Turkish population.
- Involving 134 PD patients and 140 healthy controls, the research utilized PCR-RFLP for genotyping and assessed PD symptoms with the Panic Disorder Severity Scale (PDSS).
- Results showed no link between miR-155 and PD risk/severity, but a significant protective effect (80.4%) of the CC genotype of miR-22 against PD was found, suggesting further investigation is needed.
Impact of miR-155 rs767649 Polymorphism on Rheumatoid Arthritis Activity in Egyptian Patients.
Cureus
November 2023
Medical Microbiology and Immunology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EGY.
Article Synopsis
- Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects multiple body systems and is linked to the regulation of gene expression through microRNAs (miRNAs), specifically investigating the miR-155 rs767649 polymorphism's impact on RA activity.
- A study was conducted with 66 RA patients and 50 healthy controls, focusing on clinical evaluations and assessing various laboratory parameters alongside miR-155 polymorphism using real-time PCR.
- Results showed significant differences in hemoglobin levels, ESR, serum creatinine, and anti-CCP levels between the RA patients and controls, highlighting certain genetic variants (TA, AA, TA/AA genotypes) that may offer protective effects against developing RA.
Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a Genes Polymorphisms with Papillary Thyroid Cancer Susceptibility and Prognosis.
Cancers (Basel)
January 2024
Medical Faculty of Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
Polymorphisms in long non-coding RNA and microRNA genes may play a significant role in the susceptibility and progression of papillary thyroid carcinoma (PTC). The current study investigates the polymorphisms HOTAIR rs920778, MIR155HG rs1893650, TERC rs10936599, miR-155 rs767649, miR-196a2 rs11614913 and miR-146a rs2910164 in 102 PTC patients and 106 age- and sex-matched controls of the Caucasian Serbian population, using real-time PCR. We observed differences in genotype distributions of the HOTAIR rs920778 ( = 0.
View Article and Find Full Text PDFAssociations of leptin receptors and miRNA polymorphisms with susceptibility to hypertension.
Biomed Rep
November 2023
Department of Science Education, Teachers College, Jeju National University, Jeju 63294, Republic of Korea.
Leptin receptors (LEPR) are located in the central nervous system and other tissues including adipocytes and endothelial cells, where they play a key role in mediating the effects of leptin. MicroRNA (miR/miRNA)-27a and miR-155 have been shown to play an important role in the regulation of LEPR expression and are differentially expressed in various diseases. Therefore, the present study analyzed potential associations of LEPR deletion/insertion (Del/Ins), miR-27aA>G (rs895819) and miR-155T>A (rs767649) polymorphisms with a predisposition to hypertension (HTN).
View Article and Find Full Text PDFgene polymorphism is associated with downregulation of expression, suppressor of cytokine signaling-1 overexpression, and low probability of metastatic tumor at the time of breast cancer diagnosis.
J Res Med Sci
April 2023
Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background: is a key player in inflammatory reactions, carcinogenesis, and tumor development. In this study, polymorphism of and its gene and suppressor of cytokine signaling-1 (SOCS-1) expression were investigated in relation to cancer susceptibility and development in breast cancer (BC) patients.
Materials And Methods: Polymorphism of was evaluated between a population of 174 patients with BC and 129 controls using restriction fragment length polymorphism and the expression of and SOCS-1 were examined in peripheral blood mononuclear cells (PBMCs) by real-time polymerase chain reaction.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!